• Elbasvir/Grazoprevir in HCV: Evidence and Practice

  2026-09-13

  The 2021 reference review explains how dual targeting of HCV NS5A and NS3/4A proteins combines potent viral suppression with a clinically useful resistance and safety profile. Its synthesis supports treatment decisions for genotype 1 and 4 infection, including patients with compensated cirrhosis, HIV coinfection, and advanced kidney disease.

• Y-27632 dihydrochloride: ROCK Inhibitor Workflows

  2026-09-12

  Y-27632 dihydrochloride offers reversible control of ROCK1/2 signaling for cytoskeletal assays, stem-cell handling, smooth-muscle studies, and cancer research. This practical guide connects concentration and timing decisions with the light-responsive gene-control concepts reported in a recent reference study, while keeping validated product use distinct from emerging translational ideas.

• Dorsomorphin (Compound C): From AMPK to Translation

  2026-09-11

  Dorsomorphin, also known as Compound C, is more than a conventional AMPK inhibitor. Its reversible ATP-competitive activity and parallel effects on BMP/Smad signaling make it a strategic probe for connecting energy sensing, autophagy regulation, macrophage inflammation, differentiation, and iron metabolism modulation. This article outlines how translational researchers can use the compound to test AMPK-dependent mechanisms while avoiding overinterpretation caused by pathway overlap.

• Grazoprevir hydrate: HCV Assay Workflows

  2026-09-11

  Build genotype-aware HCV replication assays around Grazoprevir hydrate, an exceptionally potent NS3/4A protease inhibitor with reported picomolar activity. The workflow connects concentration-response testing with combination, resistance, HIV/HCV coinfection, and kidney-disease research while separating assay recommendations from clinical evidence.

• PNU 74654 Workflow for Wnt Pathway Studies

  2026-09-10

  PNU 74654 provides a practical pathway-perturbation tool for testing how Wnt activity influences proliferation, differentiation, and progenitor-state decisions. This guide translates the WNT5a/GSK3/β-catenin findings from skeletal muscle research into controlled workflows for cancer, stem cell, and mechanistic signaling studies.

• Verbascoside Workflow for PKC/NF-κB Studies

  2026-09-10

  Verbascoside provides a practical chemical perturbation for dissecting PKC/NF-κB signaling in RANKL-driven osteoclastogenesis, inflammatory responses, and bone-cell assays. This workflow combines concentration planning, pathway-resolved readouts, and troubleshooting guidance while clearly separating established product data from hypotheses involving osteonecrosis research.

• Amplex Red Workflows for H2O2 Assays

  2026-09-09

  Amplex Red combines low background with sensitive fluorescence for hydrogen peroxide, peroxidase, mitochondrial, and cell-based redox assays. This practical guide covers assay setup, controls, plate-based workflows, and a critical carboxylesterase interference discovered in mitochondrial samples.

• CHIR-99021: Practical Stem Cell Workflow Guide

  2026-09-09

  CHIR-99021 (CT99021) provides selective GSK-3α/β inhibition for controlling pluripotency, Wnt/β-catenin activity, and lineage commitment. This guide translates its mechanism into practical stem cell workflows, assay controls, hepatocyte-related interpretation, and troubleshooting decisions.

• ICG001: A Precision Probe for Wnt Translational Biology

  2026-09-08

  ICG001 offers translational researchers a selective way to interrogate CBP-dependent Wnt/β-catenin signaling. By placing this Wnt/β-catenin pathway inhibitor alongside new evidence on lithium-driven exosomal Wnt10a secretion and osteogenesis, this article outlines how to distinguish pathway activation from pathway dependence across regenerative medicine, cancer, and fibrosis models.

• Optimizing hiPSC-Derived Platelet Production

  2026-09-08

  Yue and colleagues developed an optimized differentiation scheme that combines greater embryoid body input, human platelet lysate, small-molecule substitution of selected cytokines, and enhanced megakaryocyte maturation. The approach produced functional platelets more rapidly and at lower reported cost, while also clarifying which parts of the workflow are supported by direct evidence and which require further validation.

• Protease Inhibitor Cocktail: MS-SAFE Workflow

  2026-09-07

  Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) helps limit endogenous proteolysis during cell and tissue protein extraction, with an AEBSF-free formulation intended for MS-oriented workflows. It is not a complete metalloproteinase-control system unless EDTA is added separately, and phosphatase protection should be validated for the specific assay.

• N-MYC–eIF4G1 Axis in inv(16) AML

  2026-09-07

  Peramangalam et al. identify an N-MYC–eIF4G1 survival axis that helps maintain inv(16) acute myeloid leukemia. The study combines transcriptomic analysis, enhancer investigation, functional perturbation, primary leukemia models, and patient-derived xenografts to connect a previously unrecognized MYCN regulatory element with leukemic cell survival.

• Abelmoschus Polysaccharides and AMPK in Liver Fibrosis

  2026-09-05

  The reference study shows that Abelmoschus manihot polysaccharides reduce experimental liver fibrosis by coordinating macrophage polarization, hepatic stellate cell activity, and extracellular matrix remodeling through the AMPK/Nrf2/HO-1 axis. Its use of Compound C as a pathway perturbation strengthens the mechanistic interpretation while also highlighting the need for orthogonal validation of AMPK-dependent effects.

• HLY78: Wnt/β-Catenin Modulator for Research

  2026-09-04

  HLY78 is a ligand-dependent Wnt/β-catenin pathway modulator for separating receptor-proximal signaling from downstream pathway effects. Its Axin-directed mechanism supports developmental assays, zebrafish hematopoietic marker studies, and carefully controlled fibrosis-causality experiments.

• LGK-974: Precision PORCN Inhibition in Translation

  2026-09-04

  LGK-974 offers a mechanistically precise way to interrogate Wnt ligand dependence across oncology and bone biology. This thought-leadership analysis connects PORCN target engagement, biomarker strategy, experimental design, and the preclinical evidence for Wnt pathway modulation in cancer and sclerosteosis models.

8537 records 5/570 page Previous Next 12345 下5页 Last page